Thromb Haemost 1986; 55(01): 098-103
DOI: 10.1055/s-0038-1661456
Original Article
Schattauer GmbH Stuttgart

Triton X-114 Phase Separation of Platelet Membrane Glycoproteins from Normal Subjects and a Patient with Type I Thrombasthenia

U Khanduri
The Department of Medicine, St. Vincent’s Hospital, Fitzroy, Melbourne, Australia
,
S Clark
The Department of Medicine, St. Vincent’s Hospital, Fitzroy, Melbourne, Australia
,
I D Walker
*   The Department of Pathology, University of Melbourne, Parkville, Melbourne, Australia
,
K G Chamberlain
The Department of Medicine, St. Vincent’s Hospital, Fitzroy, Melbourne, Australia
,
D G Penington
The Department of Medicine, St. Vincent’s Hospital, Fitzroy, Melbourne, Australia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 05. August 1985

Accepted 14. November 1985

Publikationsdatum:
19. Juli 2018 (online)

Summary

Surface-labelled normal and thrombasthenic platelets have been subjected to phase separation in Triton X-114. Triton-rich and Triton-poor fractions have been analysed by SDS-PAGE and IEF-SDS-PAGE. Partitioning characteristics of the major glycoproteins have been defined. The Triton-rich fraction contained GPIIb, III, IV, VI, VII, VIII, GP38 and the IIb β subunit. In contrast, the Triton-poor fraction contained the HMWGP, GPIa, Ib, IIb, III, V and GPIX.

Analysis of the platelet membrane glycoproteins of a patient with Type 1 thrombasthenia has been carried out using Triton X-114. The value of the method in diagnosis of this condition and differences between our findings and those published previously are discussed.

 
  • References

  • 1 Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 1981; 256: 1604-1607
  • 2 Newman PJ, Michael AK, Kahn RA. Extraction and identification of human platelet integral membrane proteins using Triton X-114. Thromb Res 1982; 27: 221-224
  • 3 Clemetson KJ, Bienz D, Zahno M-L, Lüscher EF. Distribution of platelet glycoproteins and phosphoproteins in hydrophobic and hydrophilic phases in Triton X-114 phase partition. Biochim Biophys Acta 1984; 778: 463-469
  • 4 Caen JP. Glanzmann’s thrombasthenia. Clin Haematol 1972; 1: 383-392
  • 5 Chediak J, Telfer MC, Vander Laan B, Moxey B, Cohen I. Cycles of agglutination and disagglutination induced by Ristocetin in thrombas-thenic platelets. Br J Haematol 1979; 43: 113-126
  • 6 Rand ML, Greenberg JP, Packham MA, Mustard JF. Density subpopulation of rabbit platelets: size, protein, and sialic acid content and specific radioactivity changes following labelling with 35S sulphate in vivo. Blood 1981; 57: 741-746
  • 7 Phillips DR, Agin PP. Platelet membrane defects in Glanzmann’s thrombasthenia - evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977; 60: 535-545
  • 8 Berndt MC, Phillips DR. Purification and preliminary characterization of human platelet membrane glycoprotein V. J Biol Chem 1981; 256: 59-65
  • 9 Hogarth PM, Walker ID, Rigby AJ, McKenzie IF C. The H-2dm-1 mutation and Qa antigens. Immunogenetics 1983; 18: 617-624
  • 10 Thurlow PJ, Barlow B, Connellan JM, McKenzie IF C. Detection of glycoprotein IIb and IIIa by monoclonal antibodies. Br J Haematol 1983; 55: 123-134
  • 11 O’Farrell PH. High resolution two dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-4021
  • 12 Clemetson KJ, Capitanio A, Lüscher EF. High resolution of two dimensional gel electrophoresis of the proteins and glycoproteins of human blood platelets and platelet membranes. Biochim Biophys Acta 1979; 553: 11-24
  • 13 Bonner WM, Laskey RA. A film detection method for tritium labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem 1974; 46: 83-88
  • 14 Lepore DA, Harris RA, Penington DG. Megakaryoblast precursors in rodent bone marrow: specificity of acetylcholinesterase staining. Br J Haematol 1984; 58: 473-483
  • 15 Karas JP, Rosse WF, Kurlander RF. Characterization of the IgG Fc receptor on platelets. Blood 1982; 60: 177-182
  • 16 Phillips DR, Agin PP. Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. Biochem Biophys Res Commun 1977; 75: 940-947
  • 17 Phillips DR, Agin PP. Platelet plasma mebrane glycoproteins. Evidence for the presence of non equivalent disulphide bonds using non-reduced, reduced two dimensional gel electrophoresis. J Biol Chem 1977; 252: 2121-2126
  • 18 Berndt MC, Gregory C, Chong BH, Zola H, Castaldi PA. Additional glycoprotein defects in Bernard-Soulier syndrome: confirmation of genetic basis by parental analysis. Blood 1983; 62: 800-807
  • 19 Zucker MB, Masiello NC. The Triton X100 insoluble residue (cytoskeleton) of aggregated platelets contains increased lipid phosphorus as well as 125I-labelled glycoproteins. Blood 1983; 61: 676-683
  • 20 Kunicki TJ, Pidard D, Rosa J-P, Nurden AT. The formation of Ca++ dependent complexes of platelet membrane glycoproteins II b and III a in solution as determined by crossed immunoelectrophoresis. Blood 1981; 58: 268-278
  • 21 Rosa J-P, Kieffer N, Didry D, Pidard D, Kunicki TJ, Nurden AT. The human platelet membrane glycoprotein complex GPIIb-IIIa expresses antigenic sites not exposed on the dissociated glycoproteins. Blood 1984; 64: 1246-1253
  • 22 Brooks DA, Bradley J, Zola H. A differentiation antigen expressed selectively by a proportion of human blood cells: detection with a monoclonal antibody. Pathology 1982; 14: 5-11
  • 23 Clemetson KJ, McGregor JL, James E, Dechavanne M, Lüscher EF. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface labeling techniques and high resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-311
  • 24 Nurden AT, Didry D, Rosa J-P. Molecular defects of platelets in Bernard-Soulier syndrome. Blood Cells 1983; 9: 333-358